NRC Health Payments for Repurchase of Other Equity
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- NRC Health payments for repurchase of other equity for the quarter ending 2012-09-30 was $0.00, a 100.00% decline year-over-year.
- NRC Health payments for repurchase of other equity for the quarter ending 2012-06-30 was $61.00K.
- NRC Health payments for repurchase of other equity for the quarter ending 2012-03-31 was $466.00K, a 529.73% increase year-over-year.
- NRC Health payments for repurchase of other equity for the quarter ending 2011-12-31 was $0.00.
- NRC Health payments for repurchase of other equity for fiscal 2011 was $146.00K, a 128.13% increase from fiscal 2010.
- NRC Health payments for repurchase of other equity for fiscal 2010 was $64.00K.
| Period end | Payments for Repurchase of Other Equity 3 month | Payments for Repurchase of Other Equity 12 month |
|---|---|---|
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $527.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $599.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2012-03-31 | $466.00K 10-Q · filed 2012-05-11 | $538.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-01 | $146.00K 10-K · filed 2012-03-01 |
| 2011-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | $146.00K derived: sum of 4 quarters · filed 2012-11-07 |
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-10 | $74.00K derived: sum of 4 quarters · filed 2012-08-10 |
| 2011-03-31 | $74.00K 10-Q · filed 2012-05-11 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-01 | $64.00K 10-K · filed 2012-03-01 |
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |